跳到主要内容
  • Sign in
    Welcome !
    My account
    Logout

Enfusion, Inc. (ENFN) Stock Forecast 2025 - AI Price Prediction & Analysis

Enfusion, Inc. (ENFN) AI Stock Price Forecast & Investment Analysis

Enfusion, Inc. Stock Price Chart and Technical Analysis

Loading Enfusion, Inc. interactive price chart and technical analysis...

Enfusion, Inc. (ENFN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Enfusion, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Enfusion, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Enfusion, Inc.: Enfusion, Inc. operates in the Technology sector, making it an emerging small-cap investment.

Enfusion, Inc. (Stock Symbol: ENFN) is a leading company in the Technology sector , specifically operating within the Services-Prepackaged Software industry.

The organization employs approximately 963 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Enfusion, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Enfusion, Inc.: With $188M in annual revenue and 2.0% net margin, the company demonstrates developing profitability.

Annual Revenue: $188 million generating a 2.0% net profit margin .

Return on Equity (ROE): -364.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Enfusion, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Enfusion, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Enfusion, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Enfusion, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Enfusion, Inc.: Market positioning analysis based on available financial and operational metrics.

Enfusion, Inc. strategically competes in the highly dynamic Services-Prepackaged Software marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 66.9% gross margin, indicating strong pricing power and operational efficiency.

Enfusion, Inc. (ENFN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Enfusion, Inc. stock analysis.

Loading Enfusion, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Enfusion, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Enfusion, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Enfusion, Inc.: With a P/E ratio of 277.25, the market highly values future growth prospects.

P/E Ratio 277.25x
EPS $0.01
Book Value/Share $0.84
Revenue/Share $1.83
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Enfusion, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Enfusion, Inc.: An ROE of -364.3% indicates room for improvement in shareholder value creation.

ROE -364.3%
ROA -190.5%
ROIC -360.8%
Gross Margin 66.9%
Operating Margin 3.4%
Net Margin 2.0%
EBT Margin -245.7%
Tax Rate 24.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Enfusion, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Enfusion, Inc.: A current ratio of 11.15 indicates strong liquidity.

Current Ratio 11.15x
Quick Ratio 10.28x
Financial Leverage 1.91x
Interest Coverage -92.0x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Enfusion, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Enfusion, Inc.: Free cash flow of $-14M indicates cash challenges that need attention.

Operating Cash Flow $-5M
Free Cash Flow $-14M
Capital Spending $-9M
FCF/Sales -11.5%
CapEx/Sales 7.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Enfusion, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Enfusion, Inc.: An asset turnover of 1.16x demonstrates efficient asset utilization.

Asset Turnover 1.16x
Receivables Turnover 5.2x
Fixed Assets Turnover 8.1x
Days Sales Outstanding 70 days
Payables Period 12 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Enfusion, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Enfusion, Inc.: With annual revenue of $188M, Enfusion, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $188M
Operating Income $6M
Net Income $3M
SG&A Expense $312M
Cost of Goods Sold $39M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 82%
Cash & Short-term Investments 54%
Total Liabilities 13%
Short-term Debt 10%
Accounts Receivable 22%
Dividend & Shareholder Information
Shares Outstanding 66M
Growth Metrics (YoY)
EPS Growth 0.1%

Latest Enfusion, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Enfusion, Inc. (ENFN) stock price and investment outlook.

Enfusion, Inc. Competitors & Peer Analysis - Technology Sector

Comparative analysis of Enfusion, Inc. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACIW Unlock Forecast - 30 Days FREE Trial $5428M 21.6x 3.9x
ADBE Unlock Forecast - 30 Days FREE Trial $153379M 22.3x 13.4x
ADSK Unlock Forecast - 30 Days FREE Trial $63742M 61.0x 24.4x
AEYE Unlock Forecast - 30 Days FREE Trial $164M -61.5x 22.3x
AI Unlock Forecast - 30 Days FREE Trial $2117M -16.8x 2.7x
AIFF Unlock Forecast - 30 Days FREE Trial $39M -4.2x 7.5x
AILE Unlock Forecast - 30 Days FREE Trial $148M x 50.7x
AILEW Unlock Forecast - 30 Days FREE Trial $9M x 3.1x
AISP Unlock Forecast - 30 Days FREE Trial $94M x -7.3x
AISPW Unlock Forecast - 30 Days FREE Trial $17M x -1.3x
ALKT Unlock Forecast - 30 Days FREE Trial $2629M -75.9x 7.6x
ALRM Unlock Forecast - 30 Days FREE Trial $3611M 28.1x 4.5x
ALSAF Unlock Forecast - 30 Days FREE Trial $39M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
ALTR Unlock Forecast - 30 Days FREE Trial $0M 360.3x 0.0x
AMPL Unlock Forecast - 30 Days FREE Trial $0M -16.9x 0.0x
AMST Unlock Forecast - 30 Days FREE Trial $10M -2.6x 7.9x
ANSS Unlock Forecast - 30 Days FREE Trial $28149M 66.6x 5.0x
APCX Unlock Forecast - 30 Days FREE Trial $8M -0.8x 3.0x
APCXW Unlock Forecast - 30 Days FREE Trial $5M x 3.4x
API Unlock Forecast - 30 Days FREE Trial $1419M x 2.2x
APPF Unlock Forecast - 30 Days FREE Trial $0M 64.5x 0.0x
APPN Unlock Forecast - 30 Days FREE Trial $2827M -27.3x -56.8x
ASAN Unlock Forecast - 30 Days FREE Trial $3187M -12.4x 14.2x
ATHR Unlock Forecast - 30 Days FREE Trial $69M x 11.7x
AUID Unlock Forecast - 30 Days FREE Trial $54M -159.3x 7.0x
AVDX Unlock Forecast - 30 Days FREE Trial $2063M 1104.8x 3.0x
AVPT Unlock Forecast - 30 Days FREE Trial $3853M -86.5x 16.5x
AVPTW Unlock Forecast - 30 Days FREE Trial $1482M x 6.4x
AWRE Unlock Forecast - 30 Days FREE Trial $49M -8.1x 1.7x
BAND Unlock Forecast - 30 Days FREE Trial $462M -30.3x 1.2x
BASE Unlock Forecast - 30 Days FREE Trial $1350M -10.2x 10.9x
BB Unlock Forecast - 30 Days FREE Trial $2256M -11.9x 3.1x
BBAI Unlock Forecast - 30 Days FREE Trial $1749M -3.9x 6.6x
BIGC Unlock Forecast - 30 Days FREE Trial $404M -14.6x 10.6x
BILL Unlock Forecast - 30 Days FREE Trial $9589M -533.4x 2.4x
BKYI Unlock Forecast - 30 Days FREE Trial $5M -26.8x 0.6x
BL Unlock Forecast - 30 Days FREE Trial $3878M 44.1x 9.4x
BLIN Unlock Forecast - 30 Days FREE Trial $15M -2.4x 1.5x
BLKB Unlock Forecast - 30 Days FREE Trial $3328M 88.2x 37.8x
BLZE Unlock Forecast - 30 Days FREE Trial $137M -5.6x 3.2x
BMR Unlock Forecast - 30 Days FREE Trial $42M x 2.3x
BNIX Unlock Forecast - 30 Days FREE Trial $34M x -5.7x
BNIXR Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
BNIXW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BNZI Unlock Forecast - 30 Days FREE Trial $6M x 1.9x
BNZIW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BOX Unlock Forecast - 30 Days FREE Trial $4696M 42.9x -16.8x
BRZE Unlock Forecast - 30 Days FREE Trial $3271M -36.2x 5.5x
BSQKZ Unlock Forecast - 30 Days FREE Trial $46199M 15.6x 2.1x
BSY Unlock Forecast - 30 Days FREE Trial $17829M 70.1x 15.3x
CANG Unlock Forecast - 30 Days FREE Trial $1174M x 0.3x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCCS Unlock Forecast - 30 Days FREE Trial $6432M 396.6x 3.0x
CCLD Unlock Forecast - 30 Days FREE Trial $146M 13.0x 2.6x
CCLDO Unlock Forecast - 30 Days FREE Trial $906M 80.4x 16.2x
CCLDP Unlock Forecast - 30 Days FREE Trial $822M -14.2x 16.5x
CCRD Unlock Forecast - 30 Days FREE Trial $226M 76.0x 4.2x
CCSI Unlock Forecast - 30 Days FREE Trial $529M 6.5x -8.3x
CDNS Unlock Forecast - 30 Days FREE Trial $98859M 97.7x 19.8x
CERT Unlock Forecast - 30 Days FREE Trial $1778M 222.7x 1.7x
CFLT Unlock Forecast - 30 Days FREE Trial $6455M -15.7x 7.7x
CGNT Unlock Forecast - 30 Days FREE Trial $711M x 3.6x
CHKP Unlock Forecast - 30 Days FREE Trial $22291M x 8.0x
CLBT Unlock Forecast - 30 Days FREE Trial $4307M x 10.6x
CLPS Unlock Forecast - 30 Days FREE Trial $13M x 0.8x
COUR Unlock Forecast - 30 Days FREE Trial $1929M -14.2x 3.1x
CRM Unlock Forecast - 30 Days FREE Trial $243490M 36.5x 4.0x
CRNC Unlock Forecast - 30 Days FREE Trial $398M -0.5x 2.6x
CRWD Unlock Forecast - 30 Days FREE Trial $106599M 4606.3x 28.4x
CRWV Unlock Forecast - 30 Days FREE Trial $53110M x 20.0x
CTV Unlock Forecast - 30 Days FREE Trial $466M -21.6x 2.3x
CVLT Unlock Forecast - 30 Days FREE Trial $8387M 103.5x 23.0x
CWAN Unlock Forecast - 30 Days FREE Trial $5203M 12.8x 2.7x
CXAI Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CXAIW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CXM Unlock Forecast - 30 Days FREE Trial $2075M 17.3x 3.8x
CYBR Unlock Forecast - 30 Days FREE Trial $23205M x 9.8x
DAY Unlock Forecast - 30 Days FREE Trial $11148M 227.5x 4.1x
DBX Unlock Forecast - 30 Days FREE Trial $0M 17.8x 0.0x
DDD Unlock Forecast - 30 Days FREE Trial $392M -3.9x 1.6x
DDOG Unlock Forecast - 30 Days FREE Trial $50747M 407.3x 15.9x
DH Unlock Forecast - 30 Days FREE Trial $595M -1.3x 2.0x
DOCU Unlock Forecast - 30 Days FREE Trial $16908M 60.2x 8.5x
DOMO Unlock Forecast - 30 Days FREE Trial $0M -3.7x 0.0x
DRTTF Unlock Forecast - 30 Days FREE Trial $102M 26.4x 3.0x
DSGX Unlock Forecast - 30 Days FREE Trial $9368M x 6.3x
DT Unlock Forecast - 30 Days FREE Trial $15406M 31.3x 5.7x
DTSS Unlock Forecast - 30 Days FREE Trial $16M -6.8x 5.5x
DUOL Unlock Forecast - 30 Days FREE Trial $13338M 113.8x 13.7x
DUOT Unlock Forecast - 30 Days FREE Trial $91M -2.8x 17.8x
EA Unlock Forecast - 30 Days FREE Trial $42174M 40.5x 6.9x
EGAN Unlock Forecast - 30 Days FREE Trial $220M 76.2x 4.3x
ENFN Unlock Forecast - 30 Days FREE Trial $0M 277.3x 0.0x
ESTC Unlock Forecast - 30 Days FREE Trial $10000M 24.9x 12.3x
EVCM Unlock Forecast - 30 Days FREE Trial $2139M -59.0x 2.9x
EXFY Unlock Forecast - 30 Days FREE Trial $176M -12.3x 1.3x
FAAS Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
FAASW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
FALC Unlock Forecast - 30 Days FREE Trial $1M x x
FATN Unlock Forecast - 30 Days FREE Trial $81M x 4.0x
FCUL Unlock Forecast - 30 Days FREE Trial $11M x 233.2x
FNGR Unlock Forecast - 30 Days FREE Trial $89M -16.8x 5.5x
FROG Unlock Forecast - 30 Days FREE Trial $5818M -60.2x 7.0x
FRSH Unlock Forecast - 30 Days FREE Trial $3955M -49.0x 4.0x
FRSX Unlock Forecast - 30 Days FREE Trial $1614M x 272.2x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1106M -8.6x 1.2x
GDYN Unlock Forecast - 30 Days FREE Trial $888M 2810.7x 1.7x
GEG Unlock Forecast - 30 Days FREE Trial $122M 9.5x 1.7x
GEGGL Unlock Forecast - 30 Days FREE Trial $1098M 85.2x 15.6x
GEN Unlock Forecast - 30 Days FREE Trial $18787M 27.7x 8.3x
GENVR Unlock Forecast - 30 Days FREE Trial $5663M x 2.5x
GHST Unlock Forecast - 30 Days FREE Trial $5M x x
GLBE Unlock Forecast - 30 Days FREE Trial $6307M x 7.1x
GMGI Unlock Forecast - 30 Days FREE Trial $146M -247.8x 1.2x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0.1x x
GTLB Unlock Forecast - 30 Days FREE Trial $8373M 654.1x 9.7x
GTM Unlock Forecast - 30 Days FREE Trial $3481M x 2.1x
GWRE Unlock Forecast - 30 Days FREE Trial $22431M 648.1x 16.5x
GXAI Unlock Forecast - 30 Days FREE Trial $11M -1.3x 0.7x
HPAI Unlock Forecast - 30 Days FREE Trial $147M x 9.0x
HUBS Unlock Forecast - 30 Days FREE Trial $26471M -5033.1x 12.8x
ICCT Unlock Forecast - 30 Days FREE Trial $34M x -11.4x
IDAI Unlock Forecast - 30 Days FREE Trial $8M -0.7x 3.2x
IDN Unlock Forecast - 30 Days FREE Trial $102M -52.1x 5.8x
INFA Unlock Forecast - 30 Days FREE Trial $7504M 3931.5x 3.2x
INLX Unlock Forecast - 30 Days FREE Trial $51M 1318.3x 4.4x
INSE Unlock Forecast - 30 Days FREE Trial $273M 4.5x -116.0x
INTA Unlock Forecast - 30 Days FREE Trial $3700M -173.7x 7.1x
INTU Unlock Forecast - 30 Days FREE Trial $189862M 49.1x 9.6x
IVDA Unlock Forecast - 30 Days FREE Trial $6M -7.5x 0.8x
IVDAW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
JAMF Unlock Forecast - 30 Days FREE Trial $1269M -22.8x 1.6x
KC Unlock Forecast - 30 Days FREE Trial $64537M x 6.8x
KLTR Unlock Forecast - 30 Days FREE Trial $237M 17.7x 14.0x
KVYO Unlock Forecast - 30 Days FREE Trial $8992M -19.1x 8.2x
LAW Unlock Forecast - 30 Days FREE Trial $344M -12.7x 2.5x
LFLY Unlock Forecast - 30 Days FREE Trial $1M -0.3x -4.0x
LFLYW Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
LGTY Unlock Forecast - 30 Days FREE Trial $441M 27.8x 3.4x
LPSN Unlock Forecast - 30 Days FREE Trial $90M -0.5x -1.2x
LTESF Unlock Forecast - 30 Days FREE Trial $0M x x
LTRY Unlock Forecast - 30 Days FREE Trial $11M -0.1x 0.4x
LTRYW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
MANH Unlock Forecast - 30 Days FREE Trial $13217M 59.8x 47.4x
MAPS Unlock Forecast - 30 Days FREE Trial $174M -10.7x 5.9x
MAPSW Unlock Forecast - 30 Days FREE Trial $5M x 0.2x
MBLY Unlock Forecast - 30 Days FREE Trial $12099M -9.4x 1.0x
MDB Unlock Forecast - 30 Days FREE Trial $18161M -85.8x 6.0x
MGIC Unlock Forecast - 30 Days FREE Trial $1018M x 4.8x
MKTW Unlock Forecast - 30 Days FREE Trial $0M 6.0x 0.0x
MLNK Unlock Forecast - 30 Days FREE Trial $1530M -46.1x 3.9x
MNDY Unlock Forecast - 30 Days FREE Trial $10291M x 8.6x
MQ Unlock Forecast - 30 Days FREE Trial $2806M 51.0x 3.3x
MSFT Unlock Forecast - 30 Days FREE Trial $3720631M 36.5x 10.8x
MSGM Unlock Forecast - 30 Days FREE Trial $0M -0.7x 0.0x
MTBLY Unlock Forecast - 30 Days FREE Trial $1614M x 33.4x
MTTR Unlock Forecast - 30 Days FREE Trial $1763M -5.6x 4.4x
MYPS Unlock Forecast - 30 Days FREE Trial $122M -24.1x 0.5x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0.4x 0.0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0.3x 0.5x
NABL Unlock Forecast - 30 Days FREE Trial $1585M 553.5x 2.0x
NCNO Unlock Forecast - 30 Days FREE Trial $3544M -119.0x 3.4x
NCSYF Unlock Forecast - 30 Days FREE Trial $9446M x 2.6x
NET Unlock Forecast - 30 Days FREE Trial $0M -419.2x 0.0x
NICE Unlock Forecast - 30 Days FREE Trial $9425M x 2.6x
NOW Unlock Forecast - 30 Days FREE Trial $195457M 117.7x 17.9x
NTNX Unlock Forecast - 30 Days FREE Trial $14701M -280.8x -21.5x
NTWK Unlock Forecast - 30 Days FREE Trial $45M 32.6x 1.3x
OKTA Unlock Forecast - 30 Days FREE Trial $0M -430.9x 0.0x
ONTF Unlock Forecast - 30 Days FREE Trial $234M -6.7x 1.6x
ORCL Unlock Forecast - 30 Days FREE Trial $684063M 36.4x 33.5x
OS Unlock Forecast - 30 Days FREE Trial $5888M x 15.3x
PATH Unlock Forecast - 30 Days FREE Trial $6452M 319.9x 3.9x
PAYC Unlock Forecast - 30 Days FREE Trial $12532M 30.1x 7.0x
PCOR Unlock Forecast - 30 Days FREE Trial $10518M -134.0x 8.6x
PCTY Unlock Forecast - 30 Days FREE Trial $9729M 42.8x 7.9x
PD Unlock Forecast - 30 Days FREE Trial $1715M -23.5x 9.5x
PDFS Unlock Forecast - 30 Days FREE Trial $923M -1123.7x 3.7x
PDYN Unlock Forecast - 30 Days FREE Trial $453M -3.0x 16.0x
PDYNW Unlock Forecast - 30 Days FREE Trial $4M 0.0x 0.1x
PLTR Unlock Forecast - 30 Days FREE Trial $422073M 553.0x 71.2x
PRCH Unlock Forecast - 30 Days FREE Trial $160M 2.9x -22.8x
PRGS Unlock Forecast - 30 Days FREE Trial $1911M 33.2x 4.2x
PTC Unlock Forecast - 30 Days FREE Trial $24650M 48.1x 7.0x
PYCR Unlock Forecast - 30 Days FREE Trial $4088M -69.4x 3.1x
QLYS Unlock Forecast - 30 Days FREE Trial $4879M 26.4x 9.6x
QTWO Unlock Forecast - 30 Days FREE Trial $5467M 1119.3x 9.4x
QUBT Unlock Forecast - 30 Days FREE Trial $2593M -23.3x 11.7x
RBLX Unlock Forecast - 30 Days FREE Trial $87326M -35.7x 247.2x
RBRK Unlock Forecast - 30 Days FREE Trial $18875M x 0.0x
RCAT Unlock Forecast - 30 Days FREE Trial $1025M -91.1x 35.4x
RDVT Unlock Forecast - 30 Days FREE Trial $736M 84.6x 7.7x
RPD Unlock Forecast - 30 Days FREE Trial $1321M 51.8x 14.6x
RTCJF Unlock Forecast - 30 Days FREE Trial $35M x 1.3x
S Unlock Forecast - 30 Days FREE Trial $5924M -25.6x 3.9x
SAIL Unlock Forecast - 30 Days FREE Trial $11499M -73.2x 1.7x
SBET Unlock Forecast - 30 Days FREE Trial $1112M x 2.5x
SCWX Unlock Forecast - 30 Days FREE Trial $0M -9.8x 0.0x
SEMR Unlock Forecast - 30 Days FREE Trial $1177M 169.4x 4.2x
SHOP Unlock Forecast - 30 Days FREE Trial $187686M x 15.5x
SKIL Unlock Forecast - 30 Days FREE Trial $136M -1.4x 2.2x
SMAR Unlock Forecast - 30 Days FREE Trial $4014M -19.6x 8.5x
SMSI Unlock Forecast - 30 Days FREE Trial $14M -0.2x 0.6x
SNAL Unlock Forecast - 30 Days FREE Trial $0M -7.0x 0.0x
SNOW Unlock Forecast - 30 Days FREE Trial $0M -54.7x 0.0x
SNPS Unlock Forecast - 30 Days FREE Trial $112085M 56.1x 4.1x
SOUN Unlock Forecast - 30 Days FREE Trial $15M -10.2x -27.1x
SOUNW Unlock Forecast - 30 Days FREE Trial $M x x
SPNS Unlock Forecast - 30 Days FREE Trial $2415M x 5.0x
SPSC Unlock Forecast - 30 Days FREE Trial $4234M 51.1x 4.5x
SPT Unlock Forecast - 30 Days FREE Trial $0M -27.5x 0.0x
SQ Unlock Forecast - 30 Days FREE Trial $0M 68.5x 0.0x
SSNC Unlock Forecast - 30 Days FREE Trial $22748M 28.2x 3.3x
SSTI Unlock Forecast - 30 Days FREE Trial $157M -38.0x 2.1x
SVCO Unlock Forecast - 30 Days FREE Trial $159M x 2.0x
SWI Unlock Forecast - 30 Days FREE Trial $3173M 86.3x 2.3x
TAOP Unlock Forecast - 30 Days FREE Trial $20M x 1.3x
TDC Unlock Forecast - 30 Days FREE Trial $2025M 18.4x 11.5x
TEAM Unlock Forecast - 30 Days FREE Trial $47739M -233.9x 35.5x
TENB Unlock Forecast - 30 Days FREE Trial $3711M -81.5x 10.6x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $10806M x 7.4x
TTWO Unlock Forecast - 30 Days FREE Trial $45705M -9.7x 13.1x
TWLO Unlock Forecast - 30 Days FREE Trial $17198M 849.5x 2.1x
TYL Unlock Forecast - 30 Days FREE Trial $26886M 87.6x 7.4x
U Unlock Forecast - 30 Days FREE Trial $20611M -13.5x 6.5x
UPLD Unlock Forecast - 30 Days FREE Trial $55M -1.2x -1.5x
VBIX Unlock Forecast - 30 Days FREE Trial $32M x 7.1x
VEEV Unlock Forecast - 30 Days FREE Trial $47284M 58.4x 7.1x
VERX Unlock Forecast - 30 Days FREE Trial $0M -368.3x 0.0x
VPRB Unlock Forecast - 30 Days FREE Trial $M x x
VRNS Unlock Forecast - 30 Days FREE Trial $6444M -27.4x 18.9x
VWAV Unlock Forecast - 30 Days FREE Trial $25M x x
WBSR Unlock Forecast - 30 Days FREE Trial $M x x
WEAV Unlock Forecast - 30 Days FREE Trial $596M -36.7x 7.6x
WFCF Unlock Forecast - 30 Days FREE Trial $64M 31.4x 6.5x
WHEN Unlock Forecast - 30 Days FREE Trial $411M x 303.5x
WIMI Unlock Forecast - 30 Days FREE Trial $707M x 0.6x
WK Unlock Forecast - 30 Days FREE Trial $0M -70.2x 0.0x
XPER Unlock Forecast - 30 Days FREE Trial $350M -4.3x 0.8x
XYZ Unlock Forecast - 30 Days FREE Trial $47279M 16.0x 2.1x
YOU Unlock Forecast - 30 Days FREE Trial $2403M -51.2x 18.6x
ZDGE Unlock Forecast - 30 Days FREE Trial $42M -4.8x 1.5x
ZETA Unlock Forecast - 30 Days FREE Trial $4019M -26.5x 6.0x
ZI Unlock Forecast - 30 Days FREE Trial $3183M 346.5x 1.9x
ZSPC Unlock Forecast - 30 Days FREE Trial $37M x -3.2x
ZUO Unlock Forecast - 30 Days FREE Trial $0M -32.2x 0.0x

Frequently Asked Questions - Enfusion, Inc. Stock Forecast

How accurate are Enfusion, Inc. stock predictions?

Our AI model demonstrates 31% historical accuracy for ENFN predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Enfusion, Inc. stock price forecasts?

Our analysis considers Enfusion, Inc.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Enfusion, Inc. a good investment in 2025?

Based on our AI analysis, Enfusion, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Enfusion, Inc. forecasts updated?

Enfusion, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Enfusion, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Enfusion, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...